. "Xyzal, Levazyr, others"@en . "\uB808\uBCF4\uC138\uD2F0\uB9AC\uC9C4(Levocetirizine) \uB610\uB294 \uB808\uBCF4\uC138\uD2F0\uB9AC\uC9C4 \uC911\uC5FC\uC0B0\uC5FC(levocetirizine dihydrochloride), \uBE0C\uB79C\uB4DC\uBA85 \uC528\uC798(Xyzal)\uC740 3\uC138\uB300 \uBE44\uC9C4\uC815\uC131 \uD56D\uD788\uC2A4\uD0C0\uBBFC\uC81C\uB85C, 2\uC138\uB300 \uC138\uD2F0\uB9AC\uC9C4\uBCF4\uB2E4 \uB354\uC6B1 \uBC1C\uC804\uB41C \uD615\uD0DC\uC758 \uC57D\uBB3C\uC774\uB2E4. \uC6D0\uC778\uC774 \uBD88\uBD84\uBA85\uD55C \uC54C\uB808\uB974\uAE30 \uBE44\uC5FC\uC774\uB098 \uC7A5\uAE30\uAC04 \uC77C\uC5B4\uB098\uB294 \uB450\uB4DC\uB7EC\uAE30 \uCE58\uB8CC\uC5D0 \uC4F0\uC778\uB2E4. \uAD6C\uC138\uB300 \uD56D\uD788\uC2A4\uD0C0\uBBFC\uC81C\uBCF4\uB2E4\uB294 \uC9C4\uC815\uC131\uC774 \uC57D\uD558\uB2E4. \uAD6C\uAC15\uC73C\uB85C \uBCF5\uC6A9\uD558\uB294 \uC54C\uC57D \uD615\uD0DC\uC774\uB2E4. \uB300\uD45C\uC801\uC778 \uBD80\uC791\uC6A9\uC73C\uB85C\uB294 \uC878\uC74C, \uC785\uC548\uC758 \uAC74\uC870\uAC10, \uAE30\uCE68, \uAD6C\uD1A0, \uC124\uC0AC \uB4F1\uC774 \uC788\uB2E4. \uC784\uC2E0 \uC911 \uC0AC\uC6A9\uC740 \uC548\uC804\uD55C \uAC83\uC73C\uB85C \uCD94\uC815\uB418\uC9C0\uB9CC, \uC5F0\uAD6C\uB41C \uBC14\uAC00 \uC801\uC73C\uBA70 \uBAA8\uC720 \uC218\uC720 \uB3C4\uC911 \uC0AC\uC6A9\uC740 \uC548\uC804\uC131\uC774 \uAC80\uD1A0\uB418\uC9C0 \uC54A\uC558\uB2E4. \uB808\uBCF4\uC138\uD2F0\uB9AC\uC9C4\uC740 2\uC138\uB300 \uD56D\uD788\uC2A4\uD0C0\uBBFC\uC81C\uCC98\uB7FC \uB97C \uCC28\uB2E8\uD558\uB294 \uBC29\uC2DD\uC73C\uB85C \uC791\uC6A9\uD55C\uB2E4. \uB808\uBCF4\uC138\uD2F0\uB9AC\uC9C4\uC740 2007\uB144 \uBBF8\uAD6D\uC5D0\uC11C \uC758\uB8CC\uC6A9 \uC0AC\uC6A9 \uD5C8\uAC00\uB97C \uBC1B\uC558\uB2E4. \uB300\uD55C\uBBFC\uAD6D\uC5D0\uC11C\uB294 2006\uB144 \uC2DD\uD488\uC758\uC57D\uD488\uC548\uC804\uCC98\uC5D0\uC11C \uD5C8\uAC00\uB97C \uBC1B\uC558\uB2E4."@ko . "\u0397 \u03BB\u03B5\u03B2\u03BF\u03C3\u03B5\u03C4\u03B9\u03C1\u03B9\u03B6\u03AF\u03BD\u03B7 \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C7\u03B7\u03BC\u03B9\u03BA\u03AE \u03B4\u03C1\u03B1\u03C3\u03C4\u03B9\u03BA\u03AE \u03BF\u03C5\u03C3\u03AF\u03B1, \u03C0\u03BF\u03C5 \u03C0\u03C9\u03BB\u03B5\u03AF\u03C4\u03B1\u03B9 \u03C3\u03C4\u03B7 \u03B4\u03B9\u03C5\u03B4\u03C1\u03BF\u03C7\u03BB\u03C9\u03C1\u03B9\u03BA\u03AE \u03BC\u03BF\u03C1\u03C6\u03AE \u03C4\u03B7\u03C2 \u03BC\u03B5 \u03C4\u03B7\u03BD \u03B5\u03BC\u03C0\u03BF\u03C1\u03B9\u03BA\u03AE \u03BF\u03BD\u03BF\u03BC\u03B1\u03C3\u03AF\u03B1 Xyzal \u03AE Xozal, \u03C9\u03C2 \u03B1\u03BD\u03C4\u03B9\u03B9\u03C3\u03C4\u03B1\u03BC\u03B9\u03BD\u03B9\u03BA\u03CC \u03C6\u03AC\u03C1\u03BC\u03B1\u03BA\u03BF \u03C4\u03C1\u03AF\u03C4\u03B7\u03C2 \u03B3\u03B5\u03BD\u03B9\u03AC\u03C2 \u03C0\u03BF\u03C5 \u03C7\u03C1\u03B7\u03C3\u03B9\u03BC\u03BF\u03C0\u03BF\u03B9\u03B5\u03AF\u03C4\u03B1\u03B9 \u03B3\u03B9\u03B1 \u03C4\u03B7 \u03B8\u03B5\u03C1\u03B1\u03C0\u03B5\u03AF\u03B1 \u03C4\u03B7\u03C2 \u03B5\u03C0\u03BF\u03C7\u03B9\u03B1\u03BA\u03AE\u03C2 \u03B1\u03BB\u03BB\u03B5\u03C1\u03B3\u03B9\u03BA\u03AE\u03C2 \u03C1\u03B9\u03BD\u03AF\u03C4\u03B9\u03B4\u03B1\u03C2 \u03BA\u03B1\u03B9 \u03C4\u03B7\u03C2 \u03C7\u03C1\u03CC\u03BD\u03B9\u03B1\u03C2 \u03BA\u03BD\u03AF\u03B4\u03C9\u03C3\u03B7\u03C2 \u03AC\u03B3\u03BD\u03C9\u03C3\u03C4\u03B7\u03C2 \u03B1\u03B9\u03C4\u03AF\u03B1\u03C2. \u0395\u03AF\u03BD\u03B1\u03B9 \u03BB\u03B9\u03B3\u03CC\u03C4\u03B5\u03C1\u03BF \u03BA\u03B1\u03C4\u03B1\u03C3\u03C4\u03B1\u03BB\u03C4\u03B9\u03BA\u03AE \u03B1\u03C0\u03CC \u03C4\u03B1 \u03C0\u03B1\u03BB\u03B1\u03B9\u03CC\u03C4\u03B5\u03C1\u03B1 \u03B1\u03BD\u03C4\u03B9\u03B9\u03C3\u03C4\u03B1\u03BC\u03B9\u03BD\u03B9\u03BA\u03AC. \u039B\u03B1\u03BC\u03B2\u03AC\u03BD\u03B5\u03C4\u03B1\u03B9 \u03B1\u03C0\u03CC \u03C4\u03BF \u03C3\u03C4\u03CC\u03BC\u03B1. \u0392\u03B9\u03BF\u03C7\u03B7\u03BC\u03B9\u03BA\u03CE\u03C2, \u03B5\u03AF\u03BD\u03B1\u03B9 \u03AD\u03BD\u03B1 \u03B5\u03BD\u03B1\u03BD\u03C4\u03B9\u03BF\u03BC\u03B5\u03C1\u03AD\u03C2 \u03C4\u03B7\u03C2 \u03C3\u03B5\u03C4\u03B9\u03C1\u03B9\u03B6\u03AF\u03BD\u03B7\u03C2, \u03BA\u03B1\u03B9 \u03B1\u03C0\u03BF\u03C4\u03B5\u03BB\u03B5\u03AF \u03AD\u03BD\u03B1\u03BD \u03B9\u03C3\u03C7\u03C5\u03C1\u03CC \u03BA\u03B1\u03B9 \u03B5\u03BA\u03BB\u03B5\u03BA\u03C4\u03B9\u03BA\u03CC \u03B1\u03BD\u03C4\u03B1\u03B3\u03C9\u03BD\u03B9\u03C3\u03C4\u03AE \u03C4\u03C9\u03BD \u03C0\u03B5\u03C1\u03B9\u03C6\u03B5\u03C1\u03B9\u03BA\u03CE\u03BD \u03971 \u03C5\u03C0\u03BF\u03B4\u03BF\u03C7\u03AD\u03C9\u03BD."@el . . . "1266001"^^ . "130018"^^ . . . "2"^^ . . . . . "Levocetirizine, sold under the brand name Xyzal among others, is a second-generation antihistamine used for the treatment of allergic rhinitis (hay fever) and long term hives of unclear cause. It is less sedating than older antihistamines. It is taken by mouth. Common side effects include sleepiness, dry mouth, cough, vomiting, and diarrhea. Use in pregnancy appears safe but has not been well studied and use when breastfeeding is of unclear safety. It is classified as a second-generation antihistamine and works by blocking histamine H1-receptors."@en . . "3"^^ . "Lewocetyryzyna"@pl . . "Levocetirizina \u00E8 un farmaco antistaminico non sedativo di terza generazione, derivato dalla cetirizina, di cui rappresenta l'eutomero. Agisce inibendo i recettori dell'istamina, alleviando cos\u00EC i tipici sintomi della febbre da fieno. Sviluppato per risultare pi\u00F9 efficace e con minori effetti collaterali dei farmaci di seconda generazione, in realt\u00E0 sembra non offrire particolari vantaggi n\u00E9 svantaggi rispetto alle molecole di seconda generazione. Il farmaco \u00E8 venduto in Italia dalla UCB con il nome commerciale di Xyzal. Secondo uno studio scientifico del 2006, levocetirizina ridurrebbe gli attacchi di asma del 70% nei bambini."@it . . . . . . "Levocetirizine"@nl . "2"^^ . . . . . "\u064A\u064F\u0639\u062A\u0628\u0631 \u0644\u064A\u0641\u0648\u0633\u064A\u062A\u0631\u064A\u0632\u064A\u0646 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Levocetirizine)\u200F\u060C \u0627\u0644\u0630\u064A \u064A\u064F\u0628\u0627\u0639 \u062A\u062D\u062A \u0627\u0644\u0627\u0633\u0645 \u0627\u0644\u062A\u062C\u0627\u0631\u064A Xyzal\u060C \u0645\u0646 \u0627\u0644\u0627\u062F\u0648\u064A\u0629 \u0627\u0644\u0645\u0636\u0627\u062F\u0629 \u0644\u0644\u0647\u0633\u062A\u0627\u0645\u064A\u0646 \u0648\u0627\u0644\u0630\u064A \u064A\u0633\u062A\u062E\u062F\u0645 \u0641\u064A \u0639\u0644\u0627\u062C \u0627\u0644\u062A\u0647\u0627\u0628 \u0627\u0644\u0623\u0646\u0641 \u0627\u0644\u062A\u062D\u0633\u0633\u064A (\u062D\u0645\u0649 \u0627\u0644\u0642\u0634) \u0648\u0627\u0644\u0634\u0631\u0649. \u0648\u0647\u0648 \u0623\u0642\u0644 \u062A\u0633\u0643\u064A\u0646\u064B\u0627 \u0645\u0646 \u0645\u0636\u0627\u062F\u0627\u062A \u0627\u0644\u0647\u064A\u0633\u062A\u0627\u0645\u064A\u0646 \u0627\u0644\u0623\u0642\u062F\u0645. \u064A\u0624\u062E\u0630 \u0639\u0646 \u0637\u0631\u064A\u0642 \u0627\u0644\u0641\u0645. \u062A\u0634\u0645\u0644 \u0627\u0644\u0622\u062B\u0627\u0631 \u0627\u0644\u062C\u0627\u0646\u0628\u064A\u0629 \u0627\u0644\u0634\u0627\u0626\u0639\u0629 \u0627\u0644\u0646\u0639\u0627\u0633 \u0648\u062C\u0641\u0627\u0641 \u0627\u0644\u0641\u0645 \u0648\u0627\u0644\u0633\u0639\u0627\u0644 \u0648\u0627\u0644\u0642\u064A\u0621 \u0648\u0627\u0644\u0625\u0633\u0647\u0627\u0644. \u0627\u0644\u0627\u0633\u062A\u062E\u062F\u0627\u0645 \u0623\u062B\u0646\u0627\u0621 \u0627\u0644\u062D\u0645\u0644 \u064A\u0645\u0643\u0646 \u0623\u0646 \u064A\u0643\u0648\u0646 \u0622\u0645\u0646\u064B\u0627 \u0648\u0644\u0643\u0646 \u0644\u0645 \u064A\u062A\u0645 \u062F\u0631\u0627\u0633\u062A\u0647 \u062C\u064A\u062F\u064B\u0627 \u0648\u0627\u0633\u062A\u062E\u062F\u0627\u0645\u0647 \u0639\u0646\u062F\u0645\u0627 \u062A\u0643\u0648\u0646 \u0627\u0644\u0631\u0636\u0627\u0639\u0629 \u0627\u0644\u0637\u0628\u064A\u0639\u064A\u0629 \u0642\u062F \u064A\u0643\u0648\u0646 \u063A\u064A\u0631 \u0622\u0645\u0646. \u064A\u062A\u0645 \u062A\u0635\u0646\u064A\u0641\u0647 \u0639\u0644\u0649 \u0623\u0646\u0647 \u0645\u0636\u0627\u062F \u0644\u0644\u0647\u0633\u062A\u0627\u0645\u064A\u0646 \u0645\u0646 \u0627\u0644\u062C\u064A\u0644 \u0627\u0644\u062B\u0627\u0646\u064A \u0648\u064A\u0639\u0645\u0644 \u0639\u0644\u0649 \u0645\u0646\u0639 \u0645\u0633\u062A\u0642\u0628\u0644\u0627\u062A \u0627\u0644\u0647\u0633\u062A\u0627\u0645\u064A\u0646 H 1.\u062A\u0645\u062A \u0627\u0644\u0645\u0648\u0627\u0641\u0642\u0629 \u0639\u0644\u0649 \u0644\u064A\u0641\u0648\u0633\u064A\u062A\u0631\u064A\u0632\u064A\u0646 \u0644\u0644\u0627\u0633\u062A\u062E\u062F\u0627\u0645 \u0627\u0644\u0637\u0628\u064A \u0641\u064A \u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u0641\u064A \u0639\u0627\u0645 2007. \u0648\u0647\u0648 \u0645\u062A\u0627\u062D \u0643\u062F\u0648\u0627\u0621 \u0639\u0627\u0645. \u064A\u0643\u0644\u0641 \u0627\u0644\u0639\u0631\u0636 \u0627\u0644\u0634\u0647\u0631\u064A \u0641\u064A \u0627\u0644\u0645\u0645\u0644\u0643\u0629 \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u062F\u0627\u0626\u0631\u0629 \u0627\u0644\u0635\u062D\u0629 \u0627\u0644\u0648\u0637\u0646\u064A\u0629 \u062D\u0648\u0627\u0644\u064A 4.50 \u062C\u0646\u064A\u0647 \u0625\u0633\u062A\u0631\u0644\u064A\u0646\u064A \u0627\u0639\u062A\u0628\u0627\u0631\u064B\u0627 \u0645\u0646 \u0639\u0627\u0645 2019. \u0641\u064A \u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629\u060C \u062A\u0628\u0644\u063A \u062A\u0643\u0644\u0641\u0629 \u0627\u0644\u062C\u0645\u0644\u0629 \u0644\u0647\u0630\u0627 \u0627\u0644\u0645\u0628\u0644\u063A \u062D\u0648\u0627\u0644\u064A 3 \u062F\u0648\u0644\u0627\u0631\u0627\u062A \u0623\u0645\u0631\u064A\u0643\u064A\u0629. \u0641\u064A \u0639\u0627\u0645 2016\u060C \u0643\u0627\u0646 \u0627\u0644\u062F\u0648\u0627\u0621 \u0631\u0642\u0645 163 \u0627\u0644\u0630\u064A \u062A\u0645 \u0648\u0635\u0641\u0647 \u0641\u064A \u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u0628\u0623\u0643\u062B\u0631 \u0645\u0646 3 \u0645\u0644\u0627\u064A\u064A\u0646 \u0648\u0635\u0641\u0629 \u0637\u0628\u064A\u0629."@ar . "Levocetirizin je t\u0159et\u00ED generace nesedativn\u00EDho antihistaminika. Je vyvinut z antihistaminov\u00E9ho druh\u00E9 generace. Chemicky je levocetirizin jednodu\u0161e izolovan\u00FD levoto\u010Div\u00FD enantiomer cetirizinu (co\u017E je racem\u00E1t). V l\u00E9\u010Divech se pou\u017E\u00EDv\u00E1 zpravidla v podob\u011B soli \u2013 dihydrochloridu."@cs . . . "\u9E7D\u9178\u5DE6\u897F\u66FF\u5229\u55EA\uFF08q\u00EDn\uFF09\uFF08\u82F1\u8A9E\uFF1ALevocetirizine\uFF09\uFF0C\u53C8\u7A31\uFF1AXyzal\u3001\u9A45\u7570\u6A02\u3002\u662F\u7B2C\u4E8C\u4EE3\u6297\u7D44\u7E54\u80FA\u85E5\uFF0C\u884D\u751F\u81EA\u7B2C\u4E8C\u4EE3\u6297\u7D44\u7E54\u80FA\u85E5\u9E7D\u9178\u897F\u66FF\u5229\u55EA\uFF0C\u70BA\u9E7D\u9178\u897F\u66FF\u5229\u55EA\u5916\u6D88\u65CB\u6DF7\u5408\u7269\u7684\u5DE6\u5C0D\u6620\u7570\u69CB\u9AD4\u3002"@zh . "36000.0"^^ . . . "2099019"^^ . . . "Levocetirizine 3D ball.png"@en . "1"^^ . . "21"^^ . . . "90.0"^^ . "\u9E7D\u9178\u5DE6\u897F\u66FF\u5229\u55EA"@zh . "Levocetirizin"@de . "1549000" . . . . "a607056" . . . "as salt"@en . . "L\u00E9voc\u00E9tirizine"@fr . . "Levocetirizine dihydrochloride"@en . . "Xyzal, Levazyr, others"@en . "Levocetirizina \u00E8 un farmaco antistaminico non sedativo di terza generazione, derivato dalla cetirizina, di cui rappresenta l'eutomero. Agisce inibendo i recettori dell'istamina, alleviando cos\u00EC i tipici sintomi della febbre da fieno. Sviluppato per risultare pi\u00F9 efficace e con minori effetti collaterali dei farmaci di seconda generazione, in realt\u00E0 sembra non offrire particolari vantaggi n\u00E9 svantaggi rispetto alle molecole di seconda generazione. Il farmaco \u00E8 venduto in Italia dalla UCB con il nome commerciale di Xyzal."@it . . "Ball-and-stick model of the levocetirizine molecule"@en . . "94559" . "\u041B\u0435\u0432\u043E\u0446\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D"@ru . . "Levocetirizina"@es . . "D07402" . . "R06"@en . . . "94559"^^ . "Levocetirizin ist ein Arzneistoff aus der Gruppe der Antihistaminika, der zur symptomatischen Behandlung allergischer Erkrankungen eingesetzt wird. Stereochemisch ist Levocetirizin das aktive Enantiomer (Eutomer) des Cetirizins. Levocetirizin wurde erstmals Anfang 2001 durch die belgische Firma UCB als wirksamer Bestandteil eines Arzneimittels unter dem Namen Xusal in den Handel gebracht. Die Erstzulassung erfolgte in Deutschland. Levocetirizin wurde Ende M\u00E4rz 2019 aus der Rezeptpflicht entlassen."@de . "La Levocetirizina, que se vende com\u00FAnmente bajo el nombre de Xuzal, es un antihistam\u00EDnico utilizado para el tratamiento de la rinitis al\u00E9rgica (fiebre del heno) y urticaria de largo plazo con causas poco clara.\u200B Tiene como caracter\u00EDstica ser menos sedante que los antihistam\u00EDnicos m\u00E1s antiguos.\u200B Se toma por v\u00EDa oral. Los efectos secundarios comunes incluyen somnolencia, sequedad de boca, tos, v\u00F3mitos y diarrea.\u200B El uso durante el embarazo parece seguro, pero no ha sido bien estudiado si es seguro durante el periodo de lactancia.\u200B Est\u00E1 clasificado como un antihistam\u00EDnico de segunda generaci\u00F3n y act\u00FAa bloqueando los .\u200B"@es . . "Levocetirizine, sold under the brand name Xyzal among others, is a second-generation antihistamine used for the treatment of allergic rhinitis (hay fever) and long term hives of unclear cause. It is less sedating than older antihistamines. It is taken by mouth. Common side effects include sleepiness, dry mouth, cough, vomiting, and diarrhea. Use in pregnancy appears safe but has not been well studied and use when breastfeeding is of unclear safety. It is classified as a second-generation antihistamine and works by blocking histamine H1-receptors. Levocetirizine was approved for medical use in the United States in 2007. It is available as a generic medication. In 2020, it was the 179th most commonly prescribed medication in the United States, with more than 3 million prescriptions."@en . "AE09"@en . . . . "D08118" . . "\u9E7D\u9178\u5DE6\u897F\u66FF\u5229\u55EA\uFF08q\u00EDn\uFF09\uFF08\u82F1\u8A9E\uFF1ALevocetirizine\uFF09\uFF0C\u53C8\u7A31\uFF1AXyzal\u3001\u9A45\u7570\u6A02\u3002\u662F\u7B2C\u4E8C\u4EE3\u6297\u7D44\u7E54\u80FA\u85E5\uFF0C\u884D\u751F\u81EA\u7B2C\u4E8C\u4EE3\u6297\u7D44\u7E54\u80FA\u85E5\u9E7D\u9178\u897F\u66FF\u5229\u55EA\uFF0C\u70BA\u9E7D\u9178\u897F\u66FF\u5229\u55EA\u5916\u6D88\u65CB\u6DF7\u5408\u7269\u7684\u5DE6\u5C0D\u6620\u7570\u69CB\u9AD4\u3002"@zh . . . . "Levocetirizina"@pt . "/ Rx-only"@en . . . . . "High"@en . . . "464192413"^^ . "La l\u00E9voc\u00E9tirizine ou dichlorhydrate de l\u00E9voc\u00E9tirizine est un antihistaminique de deuxi\u00E8me g\u00E9n\u00E9ration, d\u00E9velopp\u00E9 \u00E0 partir de la c\u00E9tirizine, un antihistaminique de la m\u00EAme g\u00E9n\u00E9ration. Il est utilis\u00E9 dans le traitement de l\u2019allergie, des sympt\u00F4mes associ\u00E9s \u00E0 la rhinite allergique (incluant la rhinite allergique persistante) ainsi que des d\u00E9mangeaisons et rougeurs (urticaire). Les m\u00E9dicaments \u00E0 base de l\u00E9voc\u00E9tirizine poss\u00E8dent un certain nombre d'effets ind\u00E9sirables ; parmi ceux jug\u00E9s fr\u00E9quents ou peu fr\u00E9quents (qui surviennent chez plus de 1 patient trait\u00E9 sur 100) :"@fr . "12902"^^ . . . . "POM"@en . . . "\u064A\u064F\u0639\u062A\u0628\u0631 \u0644\u064A\u0641\u0648\u0633\u064A\u062A\u0631\u064A\u0632\u064A\u0646 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Levocetirizine)\u200F\u060C \u0627\u0644\u0630\u064A \u064A\u064F\u0628\u0627\u0639 \u062A\u062D\u062A \u0627\u0644\u0627\u0633\u0645 \u0627\u0644\u062A\u062C\u0627\u0631\u064A Xyzal\u060C \u0645\u0646 \u0627\u0644\u0627\u062F\u0648\u064A\u0629 \u0627\u0644\u0645\u0636\u0627\u062F\u0629 \u0644\u0644\u0647\u0633\u062A\u0627\u0645\u064A\u0646 \u0648\u0627\u0644\u0630\u064A \u064A\u0633\u062A\u062E\u062F\u0645 \u0641\u064A \u0639\u0644\u0627\u062C \u0627\u0644\u062A\u0647\u0627\u0628 \u0627\u0644\u0623\u0646\u0641 \u0627\u0644\u062A\u062D\u0633\u0633\u064A (\u062D\u0645\u0649 \u0627\u0644\u0642\u0634) \u0648\u0627\u0644\u0634\u0631\u0649. \u0648\u0647\u0648 \u0623\u0642\u0644 \u062A\u0633\u0643\u064A\u0646\u064B\u0627 \u0645\u0646 \u0645\u0636\u0627\u062F\u0627\u062A \u0627\u0644\u0647\u064A\u0633\u062A\u0627\u0645\u064A\u0646 \u0627\u0644\u0623\u0642\u062F\u0645. \u064A\u0624\u062E\u0630 \u0639\u0646 \u0637\u0631\u064A\u0642 \u0627\u0644\u0641\u0645."@ar . "Levocetirizine"@en . . "\u041B\u0435\u0432\u043E\u0446\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D \u2014 \u0430\u043D\u0442\u0438\u0433\u0438\u0441\u0442\u0430\u043C\u0438\u043D\u043D\u044B\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442, \u0434\u0435\u0439\u0441\u0442\u0432\u0443\u044E\u0449\u0438\u0439 \u0438\u0437\u043E\u043C\u0435\u0440 \u0426\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D\u0430."@ru . . . . "Liver 14% CYP3A4"@en . . "Lewocetyryzyna \u2013 organiczny zwi\u0105zek chemiczny, antagonista receptora H1, aktywny lewoskr\u0119tny enancjomer cetyryzyny o silniejszym dzia\u0142aniu. W postaci dichlorowodorku jest stosowana w leczeniu alergicznego nie\u017Cytu nosa, alergicznego zapalenia spoj\u00F3wek oraz przewlek\u0142ej pokrzywki idiopatycznej. Preparaty produkowane s\u0105 w formie tabletek lub roztworu doustnego."@pl . . . . . . . . "Levocetirizin"@cs . . . . "1214"^^ . "D08118"@en . "130018-77-8" . "La l\u00E9voc\u00E9tirizine ou dichlorhydrate de l\u00E9voc\u00E9tirizine est un antihistaminique de deuxi\u00E8me g\u00E9n\u00E9ration, d\u00E9velopp\u00E9 \u00E0 partir de la c\u00E9tirizine, un antihistaminique de la m\u00EAme g\u00E9n\u00E9ration. Il est utilis\u00E9 dans le traitement de l\u2019allergie, des sympt\u00F4mes associ\u00E9s \u00E0 la rhinite allergique (incluant la rhinite allergique persistante) ainsi que des d\u00E9mangeaisons et rougeurs (urticaire). Chimiquement parlant, la l\u00E9voc\u00E9tirizine est l'\u00E9nantiom\u00E8re actif de la c\u00E9tirizine, ce qui signifie que l'\u00E9nantiom\u00E9re inactif a \u00E9t\u00E9 supprim\u00E9 du produit final. Cliniquement parlant, la l\u00E9voc\u00E9tirizine n'a donc aucun effet suppl\u00E9mentaire par rapport \u00E0 la c\u00E9tirizine. Le m\u00E9dicament est commercialis\u00E9 par UCB Pharma sous les noms de Xyzal, Xyzall ou Xozal. Il a aussi \u00E9t\u00E9 commercialis\u00E9 sous le nom de Zyrtec. Il est \u00E9galement disponible sous forme g\u00E9n\u00E9rique.Xyzal existe en comprim\u00E9 de 5 mg et il est commercialis\u00E9 par UCB Pharma. Xyzal fut lanc\u00E9 en 2001. Les m\u00E9dicaments \u00E0 base de l\u00E9voc\u00E9tirizine poss\u00E8dent un certain nombre d'effets ind\u00E9sirables ; parmi ceux jug\u00E9s fr\u00E9quents ou peu fr\u00E9quents (qui surviennent chez plus de 1 patient trait\u00E9 sur 100) : \n* somnolence/endormissement \n* maux de t\u00EAte \n* s\u00E9cheresse de la bouche \n* maux de ventre \n* \u00E9puisement"@fr . "OTC"@en . . "Kidney and fecal"@en . . . . . . . "changed"@en . . . . . . . "\uB808\uBCF4\uC138\uD2F0\uB9AC\uC9C4"@ko . . . "\u0644\u064A\u0641\u0648\u0633\u064A\u062A\u0631\u064A\u0632\u064A\u0646"@ar . . . . . . . "DB06282"@en . "\u041B\u0435\u0432\u043E\u0446\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D"@uk . . . "Levocetirizine (ook: L-cetirizine, in de vorm van levocetirizine dihydrochloride, bekend onder de merknamen Xyzal, Xyzall, Xusal, Xozal en Xazal) is een antihistaminicum van de derde generatie ontwikkeld door het Belgische UCB. Het wordt vaak voorgeschreven bij mensen met hooikoorts. Het maakt weinig tot niet slaperig, een belangrijke bijwerking van vele oudere middelen."@nl . . . . . . . . "D07402"@en . "\u041B\u0435\u0432\u043E\u0446\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D \u2014 \u0430\u043D\u0442\u0438\u0433\u0438\u0441\u0442\u0430\u043C\u0438\u043D\u043D\u044B\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442, \u0434\u0435\u0439\u0441\u0442\u0432\u0443\u044E\u0449\u0438\u0439 \u0438\u0437\u043E\u043C\u0435\u0440 \u0426\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D\u0430."@ru . . . "6"^^ . "1"^^ . . . . . "Clc1ccc[C@H]c3ccccc3"@en . . "\uB808\uBCF4\uC138\uD2F0\uB9AC\uC9C4(Levocetirizine) \uB610\uB294 \uB808\uBCF4\uC138\uD2F0\uB9AC\uC9C4 \uC911\uC5FC\uC0B0\uC5FC(levocetirizine dihydrochloride), \uBE0C\uB79C\uB4DC\uBA85 \uC528\uC798(Xyzal)\uC740 3\uC138\uB300 \uBE44\uC9C4\uC815\uC131 \uD56D\uD788\uC2A4\uD0C0\uBBFC\uC81C\uB85C, 2\uC138\uB300 \uC138\uD2F0\uB9AC\uC9C4\uBCF4\uB2E4 \uB354\uC6B1 \uBC1C\uC804\uB41C \uD615\uD0DC\uC758 \uC57D\uBB3C\uC774\uB2E4. \uC6D0\uC778\uC774 \uBD88\uBD84\uBA85\uD55C \uC54C\uB808\uB974\uAE30 \uBE44\uC5FC\uC774\uB098 \uC7A5\uAE30\uAC04 \uC77C\uC5B4\uB098\uB294 \uB450\uB4DC\uB7EC\uAE30 \uCE58\uB8CC\uC5D0 \uC4F0\uC778\uB2E4. \uAD6C\uC138\uB300 \uD56D\uD788\uC2A4\uD0C0\uBBFC\uC81C\uBCF4\uB2E4\uB294 \uC9C4\uC815\uC131\uC774 \uC57D\uD558\uB2E4. \uAD6C\uAC15\uC73C\uB85C \uBCF5\uC6A9\uD558\uB294 \uC54C\uC57D \uD615\uD0DC\uC774\uB2E4. \uB300\uD45C\uC801\uC778 \uBD80\uC791\uC6A9\uC73C\uB85C\uB294 \uC878\uC74C, \uC785\uC548\uC758 \uAC74\uC870\uAC10, \uAE30\uCE68, \uAD6C\uD1A0, \uC124\uC0AC \uB4F1\uC774 \uC788\uB2E4. \uC784\uC2E0 \uC911 \uC0AC\uC6A9\uC740 \uC548\uC804\uD55C \uAC83\uC73C\uB85C \uCD94\uC815\uB418\uC9C0\uB9CC, \uC5F0\uAD6C\uB41C \uBC14\uAC00 \uC801\uC73C\uBA70 \uBAA8\uC720 \uC218\uC720 \uB3C4\uC911 \uC0AC\uC6A9\uC740 \uC548\uC804\uC131\uC774 \uAC80\uD1A0\uB418\uC9C0 \uC54A\uC558\uB2E4. \uB808\uBCF4\uC138\uD2F0\uB9AC\uC9C4\uC740 2\uC138\uB300 \uD56D\uD788\uC2A4\uD0C0\uBBFC\uC81C\uCC98\uB7FC \uB97C \uCC28\uB2E8\uD558\uB294 \uBC29\uC2DD\uC73C\uB85C \uC791\uC6A9\uD55C\uB2E4. \uB808\uBCF4\uC138\uD2F0\uB9AC\uC9C4\uC740 2007\uB144 \uBBF8\uAD6D\uC5D0\uC11C \uC758\uB8CC\uC6A9 \uC0AC\uC6A9 \uD5C8\uAC00\uB97C \uBC1B\uC558\uB2E4. \uB300\uD55C\uBBFC\uAD6D\uC5D0\uC11C\uB294 2006\uB144 \uC2DD\uD488\uC758\uC57D\uD488\uC548\uC804\uCC98\uC5D0\uC11C \uD5C8\uAC00\uB97C \uBC1B\uC558\uB2E4."@ko . . . . "Levocetirizina (DCI; nomes comerciais: Zyxem, Xyzal, entre outros) \u00E9 um anti-histam\u00EDnico de segunda gera\u00E7\u00E3o utilizado em tratamento de rinite al\u00E9rgica (febre do feno) e casos de urtic\u00E1ria de origem incerta e longa dura\u00E7\u00E3o. \u00C9 menos sedativo que os anti-histam\u00EDnicos de primeira gera\u00E7\u00E3o. \u00C9 tomado por via oral. Os efeitos adversos comuns incluem sonol\u00EAncia, boca seca, tosse, v\u00F4mito e diarreia. O uso na gravidez parece seguro, mas faltam evid\u00EAncias mais robustas para definir seu perfil de seguran\u00E7a, enquanto o uso durante amamenta\u00E7\u00E3o \u00E9 de seguran\u00E7a incerta. \u00C9 classificado como um anti-histam\u00EDnico de segunda gera\u00E7\u00E3o e atua bloqueando os receptores de histamina H1. A levocetirizina foi aprovada para uso m\u00E9dico nos Estados Unidos em 2007. Est\u00E1 dispon\u00EDvel como medicamento gen\u00E9rico. Em 2019, foi o 193\u00BA medicamento mais prescrito nos Estados Unidos, com mais de 2 milh\u00F5es de prescri\u00E7\u00F5es."@pt . "\u041B\u0435\u0432\u043E\u0446\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D \u2014 \u0441\u0438\u043D\u0442\u0435\u0442\u0438\u0447\u043D\u0438\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442, \u0449\u043E \u0454 \u043F\u043E\u0445\u0456\u0434\u043D\u0438\u043C \u043F\u0456\u043F\u0435\u0440\u0438\u0434\u0438\u043D\u0443 \u0442\u0430 \u043D\u0430\u043B\u0435\u0436\u0438\u0442\u044C \u0434\u043E \u0430\u043D\u0442\u0438\u0433\u0456\u0441\u0442\u0430\u043C\u0456\u043D\u043D\u0438\u0445 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0456\u0432 \u0406\u0406\u0406 \u043F\u043E\u043A\u043E\u043B\u0456\u043D\u043D\u044F, \u0434\u043B\u044F \u043F\u0435\u0440\u043E\u0440\u0430\u043B\u044C\u043D\u043E\u0433\u043E \u0437\u0430\u0441\u0442\u043E\u0441\u0443\u0432\u0430\u043D\u043D\u044F. \u0423 \u0432\u0438\u0433\u043B\u044F\u0434\u0456 \u0434\u0438\u0433\u0456\u0434\u0440\u043E\u0445\u043B\u043E\u0440\u0438\u0434\u0443 \u0432\u0438\u043A\u043E\u0440\u0438\u0441\u0442\u043E\u0432\u0443\u0454\u0442\u044C\u0441\u044F \u0434\u043B\u044F \u043B\u0456\u043A\u0443\u0432\u0430\u043D\u043D\u044F \u0430\u043B\u0435\u0440\u0433\u0456\u0447\u043D\u043E\u0433\u043E \u043D\u0435\u0436\u0438\u0442\u044E \u043D\u043E\u0441\u0443 \u0442\u0430 \u0430\u043B\u0435\u0440\u0433\u0456\u0447\u043D\u043E\u0433\u043E \u043A\u043E\u043D'\u044E\u043D\u043A\u0442\u0438\u0432\u0456\u0442\u0443. \u0417\u0430 \u0445\u0456\u043C\u0456\u0447\u043D\u043E\u044E \u0441\u0442\u0440\u0443\u043A\u0442\u0443\u0440\u043E\u044E \u0454 \u043B\u0456\u0432\u043E\u043E\u0431\u0435\u0440\u0442\u0430\u044E\u0447\u0438\u043C \u0456\u0437\u043E\u043C\u0435\u0440\u043E\u043C \u0446\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D\u0443. \u0423\u043F\u0435\u0440\u0448\u0435 \u043B\u0435\u0432\u043E\u0446\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D \u043E\u0442\u0440\u0438\u043C\u0430\u043D\u0438\u0439 \u0456\u0437 \u0441\u0443\u043C\u0456\u0448\u0456 \u0435\u043D\u0430\u043D\u0442\u0456\u043E\u043C\u0435\u0440\u0456\u0432 \u0446\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D\u0443 \u0432 2001 \u0440\u043E\u0446\u0456 \u0443 \u0411\u0435\u043B\u044C\u0433\u0456\u0457 \u0442\u0430 \u0437\u0430\u0440\u0435\u0454\u0441\u0442\u0440\u043E\u0432\u0430\u043D\u0438\u0439 \u043A\u043E\u043C\u043F\u0430\u043D\u0456\u0454\u044E \u043F\u0456\u0434 \u0442\u043E\u0440\u0433\u043E\u0432\u0435\u043B\u044C\u043D\u043E\u044E \u043C\u0430\u0440\u043A\u043E\u044E \u00AB\u041A\u0441\u0438\u0437\u0430\u043B\u00BB."@uk . "1549000"^^ . . . . . "1201191" . "Levocetirizine (ook: L-cetirizine, in de vorm van levocetirizine dihydrochloride, bekend onder de merknamen Xyzal, Xyzall, Xusal, Xozal en Xazal) is een antihistaminicum van de derde generatie ontwikkeld door het Belgische UCB. Het wordt vaak voorgeschreven bij mensen met hooikoorts. Het maakt weinig tot niet slaperig, een belangrijke bijwerking van vele oudere middelen."@nl . . "1201191"^^ . . "\u041B\u0435\u0432\u043E\u0446\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D \u2014 \u0441\u0438\u043D\u0442\u0435\u0442\u0438\u0447\u043D\u0438\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442, \u0449\u043E \u0454 \u043F\u043E\u0445\u0456\u0434\u043D\u0438\u043C \u043F\u0456\u043F\u0435\u0440\u0438\u0434\u0438\u043D\u0443 \u0442\u0430 \u043D\u0430\u043B\u0435\u0436\u0438\u0442\u044C \u0434\u043E \u0430\u043D\u0442\u0438\u0433\u0456\u0441\u0442\u0430\u043C\u0456\u043D\u043D\u0438\u0445 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0456\u0432 \u0406\u0406\u0406 \u043F\u043E\u043A\u043E\u043B\u0456\u043D\u043D\u044F, \u0434\u043B\u044F \u043F\u0435\u0440\u043E\u0440\u0430\u043B\u044C\u043D\u043E\u0433\u043E \u0437\u0430\u0441\u0442\u043E\u0441\u0443\u0432\u0430\u043D\u043D\u044F. \u0423 \u0432\u0438\u0433\u043B\u044F\u0434\u0456 \u0434\u0438\u0433\u0456\u0434\u0440\u043E\u0445\u043B\u043E\u0440\u0438\u0434\u0443 \u0432\u0438\u043A\u043E\u0440\u0438\u0441\u0442\u043E\u0432\u0443\u0454\u0442\u044C\u0441\u044F \u0434\u043B\u044F \u043B\u0456\u043A\u0443\u0432\u0430\u043D\u043D\u044F \u0430\u043B\u0435\u0440\u0433\u0456\u0447\u043D\u043E\u0433\u043E \u043D\u0435\u0436\u0438\u0442\u044E \u043D\u043E\u0441\u0443 \u0442\u0430 \u0430\u043B\u0435\u0440\u0433\u0456\u0447\u043D\u043E\u0433\u043E \u043A\u043E\u043D'\u044E\u043D\u043A\u0442\u0438\u0432\u0456\u0442\u0443. \u0417\u0430 \u0445\u0456\u043C\u0456\u0447\u043D\u043E\u044E \u0441\u0442\u0440\u0443\u043A\u0442\u0443\u0440\u043E\u044E \u0454 \u043B\u0456\u0432\u043E\u043E\u0431\u0435\u0440\u0442\u0430\u044E\u0447\u0438\u043C \u0456\u0437\u043E\u043C\u0435\u0440\u043E\u043C \u0446\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D\u0443. \u0423\u043F\u0435\u0440\u0448\u0435 \u043B\u0435\u0432\u043E\u0446\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D \u043E\u0442\u0440\u0438\u043C\u0430\u043D\u0438\u0439 \u0456\u0437 \u0441\u0443\u043C\u0456\u0448\u0456 \u0435\u043D\u0430\u043D\u0442\u0456\u043E\u043C\u0435\u0440\u0456\u0432 \u0446\u0435\u0442\u0438\u0440\u0438\u0437\u0438\u043D\u0443 \u0432 2001 \u0440\u043E\u0446\u0456 \u0443 \u0411\u0435\u043B\u044C\u0433\u0456\u0457 \u0442\u0430 \u0437\u0430\u0440\u0435\u0454\u0441\u0442\u0440\u043E\u0432\u0430\u043D\u0438\u0439 \u043A\u043E\u043C\u043F\u0430\u043D\u0456\u0454\u044E \u043F\u0456\u0434 \u0442\u043E\u0440\u0433\u043E\u0432\u0435\u043B\u044C\u043D\u043E\u044E \u043C\u0430\u0440\u043A\u043E\u044E \u00AB\u041A\u0441\u0438\u0437\u0430\u043B\u00BB."@uk . . "Levocetirizina (DCI; nomes comerciais: Zyxem, Xyzal, entre outros) \u00E9 um anti-histam\u00EDnico de segunda gera\u00E7\u00E3o utilizado em tratamento de rinite al\u00E9rgica (febre do feno) e casos de urtic\u00E1ria de origem incerta e longa dura\u00E7\u00E3o. \u00C9 menos sedativo que os anti-histam\u00EDnicos de primeira gera\u00E7\u00E3o. \u00C9 tomado por via oral. A levocetirizina foi aprovada para uso m\u00E9dico nos Estados Unidos em 2007. Est\u00E1 dispon\u00EDvel como medicamento gen\u00E9rico. Em 2019, foi o 193\u00BA medicamento mais prescrito nos Estados Unidos, com mais de 2 milh\u00F5es de prescri\u00E7\u00F5es."@pt . "Levocetirizin ist ein Arzneistoff aus der Gruppe der Antihistaminika, der zur symptomatischen Behandlung allergischer Erkrankungen eingesetzt wird. Stereochemisch ist Levocetirizin das aktive Enantiomer (Eutomer) des Cetirizins. Levocetirizin wurde erstmals Anfang 2001 durch die belgische Firma UCB als wirksamer Bestandteil eines Arzneimittels unter dem Namen Xusal in den Handel gebracht. Die Erstzulassung erfolgte in Deutschland. Levocetirizin wurde Ende M\u00E4rz 2019 aus der Rezeptpflicht entlassen."@de . . . . "La Levocetirizina, que se vende com\u00FAnmente bajo el nombre de Xuzal, es un antihistam\u00EDnico utilizado para el tratamiento de la rinitis al\u00E9rgica (fiebre del heno) y urticaria de largo plazo con causas poco clara.\u200B Tiene como caracter\u00EDstica ser menos sedante que los antihistam\u00EDnicos m\u00E1s antiguos.\u200B Se toma por v\u00EDa oral."@es . . . "Levocetirizin je t\u0159et\u00ED generace nesedativn\u00EDho antihistaminika. Je vyvinut z antihistaminov\u00E9ho druh\u00E9 generace. Chemicky je levocetirizin jednodu\u0161e izolovan\u00FD levoto\u010Div\u00FD enantiomer cetirizinu (co\u017E je racem\u00E1t). V l\u00E9\u010Divech se pou\u017E\u00EDv\u00E1 zpravidla v podob\u011B soli \u2013 dihydrochloridu."@cs . . "LCR"@en . . . . . "ZKLPARSLTMPFCP-OAQYLSRUSA-N"@en . "Levocetirizine"@en . "6U5EA9RT2O" . "DB06282" . . . . . . "Lewocetyryzyna \u2013 organiczny zwi\u0105zek chemiczny, antagonista receptora H1, aktywny lewoskr\u0119tny enancjomer cetyryzyny o silniejszym dzia\u0142aniu. W postaci dichlorowodorku jest stosowana w leczeniu alergicznego nie\u017Cytu nosa, alergicznego zapalenia spoj\u00F3wek oraz przewlek\u0142ej pokrzywki idiopatycznej. Preparaty produkowane s\u0105 w formie tabletek lub roztworu doustnego."@pl . . . . "\u039B\u03B5\u03B2\u03BF\u03C3\u03B5\u03C4\u03B9\u03C1\u03B9\u03B6\u03AF\u03BD\u03B7"@el . . "Levocetirizina"@it . "a607056"@en . . "200"^^ . "25"^^ . "1120503029"^^ . "\u0397 \u03BB\u03B5\u03B2\u03BF\u03C3\u03B5\u03C4\u03B9\u03C1\u03B9\u03B6\u03AF\u03BD\u03B7 \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C7\u03B7\u03BC\u03B9\u03BA\u03AE \u03B4\u03C1\u03B1\u03C3\u03C4\u03B9\u03BA\u03AE \u03BF\u03C5\u03C3\u03AF\u03B1, \u03C0\u03BF\u03C5 \u03C0\u03C9\u03BB\u03B5\u03AF\u03C4\u03B1\u03B9 \u03C3\u03C4\u03B7 \u03B4\u03B9\u03C5\u03B4\u03C1\u03BF\u03C7\u03BB\u03C9\u03C1\u03B9\u03BA\u03AE \u03BC\u03BF\u03C1\u03C6\u03AE \u03C4\u03B7\u03C2 \u03BC\u03B5 \u03C4\u03B7\u03BD \u03B5\u03BC\u03C0\u03BF\u03C1\u03B9\u03BA\u03AE \u03BF\u03BD\u03BF\u03BC\u03B1\u03C3\u03AF\u03B1 Xyzal \u03AE Xozal, \u03C9\u03C2 \u03B1\u03BD\u03C4\u03B9\u03B9\u03C3\u03C4\u03B1\u03BC\u03B9\u03BD\u03B9\u03BA\u03CC \u03C6\u03AC\u03C1\u03BC\u03B1\u03BA\u03BF \u03C4\u03C1\u03AF\u03C4\u03B7\u03C2 \u03B3\u03B5\u03BD\u03B9\u03AC\u03C2 \u03C0\u03BF\u03C5 \u03C7\u03C1\u03B7\u03C3\u03B9\u03BC\u03BF\u03C0\u03BF\u03B9\u03B5\u03AF\u03C4\u03B1\u03B9 \u03B3\u03B9\u03B1 \u03C4\u03B7 \u03B8\u03B5\u03C1\u03B1\u03C0\u03B5\u03AF\u03B1 \u03C4\u03B7\u03C2 \u03B5\u03C0\u03BF\u03C7\u03B9\u03B1\u03BA\u03AE\u03C2 \u03B1\u03BB\u03BB\u03B5\u03C1\u03B3\u03B9\u03BA\u03AE\u03C2 \u03C1\u03B9\u03BD\u03AF\u03C4\u03B9\u03B4\u03B1\u03C2 \u03BA\u03B1\u03B9 \u03C4\u03B7\u03C2 \u03C7\u03C1\u03CC\u03BD\u03B9\u03B1\u03C2 \u03BA\u03BD\u03AF\u03B4\u03C9\u03C3\u03B7\u03C2 \u03AC\u03B3\u03BD\u03C9\u03C3\u03C4\u03B7\u03C2 \u03B1\u03B9\u03C4\u03AF\u03B1\u03C2. \u0395\u03AF\u03BD\u03B1\u03B9 \u03BB\u03B9\u03B3\u03CC\u03C4\u03B5\u03C1\u03BF \u03BA\u03B1\u03C4\u03B1\u03C3\u03C4\u03B1\u03BB\u03C4\u03B9\u03BA\u03AE \u03B1\u03C0\u03CC \u03C4\u03B1 \u03C0\u03B1\u03BB\u03B1\u03B9\u03CC\u03C4\u03B5\u03C1\u03B1 \u03B1\u03BD\u03C4\u03B9\u03B9\u03C3\u03C4\u03B1\u03BC\u03B9\u03BD\u03B9\u03BA\u03AC. \u039B\u03B1\u03BC\u03B2\u03AC\u03BD\u03B5\u03C4\u03B1\u03B9 \u03B1\u03C0\u03CC \u03C4\u03BF \u03C3\u03C4\u03CC\u03BC\u03B1. \u0392\u03B9\u03BF\u03C7\u03B7\u03BC\u03B9\u03BA\u03CE\u03C2, \u03B5\u03AF\u03BD\u03B1\u03B9 \u03AD\u03BD\u03B1 \u03B5\u03BD\u03B1\u03BD\u03C4\u03B9\u03BF\u03BC\u03B5\u03C1\u03AD\u03C2 \u03C4\u03B7\u03C2 \u03C3\u03B5\u03C4\u03B9\u03C1\u03B9\u03B6\u03AF\u03BD\u03B7\u03C2, \u03BA\u03B1\u03B9 \u03B1\u03C0\u03BF\u03C4\u03B5\u03BB\u03B5\u03AF \u03AD\u03BD\u03B1\u03BD \u03B9\u03C3\u03C7\u03C5\u03C1\u03CC \u03BA\u03B1\u03B9 \u03B5\u03BA\u03BB\u03B5\u03BA\u03C4\u03B9\u03BA\u03CC \u03B1\u03BD\u03C4\u03B1\u03B3\u03C9\u03BD\u03B9\u03C3\u03C4\u03AE \u03C4\u03C9\u03BD \u03C0\u03B5\u03C1\u03B9\u03C6\u03B5\u03C1\u03B9\u03BA\u03CE\u03BD \u03971 \u03C5\u03C0\u03BF\u03B4\u03BF\u03C7\u03AD\u03C9\u03BD. \u039F\u03B9 \u03C3\u03C5\u03C7\u03BD\u03AD\u03C2 \u03B1\u03BD\u03B5\u03C0\u03B9\u03B8\u03CD\u03BC\u03B7\u03C4\u03B5\u03C2 \u03B5\u03BD\u03AD\u03C1\u03B3\u03B5\u03B9\u03B5\u03C2 \u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03BF\u03C5\u03BD \u03C5\u03C0\u03BD\u03B7\u03BB\u03AF\u03B1, \u03BE\u03B7\u03C1\u03BF\u03C3\u03C4\u03BF\u03BC\u03AF\u03B1, \u03B2\u03AE\u03C7\u03B1, \u03B5\u03BC\u03B5\u03C4\u03CC \u03BA\u03B1\u03B9 \u03B4\u03B9\u03AC\u03C1\u03C1\u03BF\u03B9\u03B1. \u0397 \u03C7\u03C1\u03AE\u03C3\u03B7 \u03BA\u03B1\u03C4\u03AC \u03C4\u03B7 \u03B4\u03B9\u03AC\u03C1\u03BA\u03B5\u03B9\u03B1 \u03C4\u03B7\u03C2 \u03B5\u03B3\u03BA\u03C5\u03BC\u03BF\u03C3\u03CD\u03BD\u03B7\u03C2 \u03C6\u03B1\u03AF\u03BD\u03B5\u03C4\u03B1\u03B9 \u03B1\u03C3\u03C6\u03B1\u03BB\u03AE\u03C2 \u03B1\u03BB\u03BB\u03AC \u03B4\u03B5\u03BD \u03AD\u03C7\u03B5\u03B9 \u03BC\u03B5\u03BB\u03B5\u03C4\u03B7\u03B8\u03B5\u03AF \u03BA\u03B1\u03BB\u03AC \u03BA\u03B1\u03B9 \u03B7 \u03C7\u03C1\u03AE\u03C3\u03B7 \u03BA\u03B1\u03C4\u03AC \u03C4\u03BF\u03BD \u03B8\u03B7\u03BB\u03B1\u03C3\u03BC\u03CC \u03B5\u03AF\u03BD\u03B1\u03B9 \u03B1\u03C3\u03B1\u03C6\u03AE\u03C2. \u03A4\u03B1\u03BE\u03B9\u03BD\u03BF\u03BC\u03B5\u03AF\u03C4\u03B1\u03B9 \u03C9\u03C2 \u03B1\u03BD\u03C4\u03B9\u03B9\u03C3\u03C4\u03B1\u03BC\u03B9\u03BD\u03B9\u03BA\u03CC \u03B4\u03B5\u03CD\u03C4\u03B5\u03C1\u03B7\u03C2 \u03B3\u03B5\u03BD\u03B9\u03AC\u03C2 \u03BA\u03B1\u03B9 \u03B4\u03C1\u03B1 \u03B1\u03BD\u03B1\u03C3\u03C4\u03AD\u03BB\u03BB\u03BF\u03BD\u03C4\u03B1\u03C2 \u03C4\u03BF\u03C5\u03C2 \u03C5\u03C0\u03BF\u03B4\u03BF\u03C7\u03B5\u03AF\u03C2 H1 \u03C4\u03B7\u03C2 . \u0397 \u03BB\u03B5\u03B2\u03BF\u03C3\u03B5\u03C4\u03B9\u03C1\u03B9\u03B6\u03AF\u03BD\u03B7 \u03BA\u03C5\u03BA\u03BB\u03BF\u03C6\u03CC\u03C1\u03B7\u03C3\u03B5 \u03B3\u03B9\u03B1 \u03C0\u03C1\u03CE\u03C4\u03B7 \u03C6\u03BF\u03C1\u03AC \u03C3\u03C4\u03B7\u03BD \u03B5\u03C5\u03C1\u03C9\u03C0\u03B1\u03CA\u03BA\u03AE \u03B1\u03B3\u03BF\u03C1\u03AC \u03C4\u03BF 2001. \u0397 \u03BB\u03B5\u03B2\u03BF\u03C3\u03B5\u03C4\u03B9\u03C1\u03B9\u03B6\u03AF\u03BD\u03B7 \u03B5\u03B3\u03BA\u03C1\u03AF\u03B8\u03B7\u03BA\u03B5 \u03B3\u03B9\u03B1 \u03B9\u03B1\u03C4\u03C1\u03B9\u03BA\u03AE \u03C7\u03C1\u03AE\u03C3\u03B7 \u03C3\u03C4\u03B9\u03C2 \u0397\u03BD\u03C9\u03BC\u03AD\u03BD\u03B5\u03C2 \u03A0\u03BF\u03BB\u03B9\u03C4\u03B5\u03AF\u03B5\u03C2 \u0391\u03BC\u03B5\u03C1\u03B9\u03BA\u03AE\u03C2 \u03C4\u03BF 2007. \u0394\u03B9\u03B1\u03C4\u03AF\u03B8\u03B5\u03C4\u03B1\u03B9 \u03C9\u03C2 \u03B3\u03B5\u03BD\u03CC\u03C3\u03B7\u03BC\u03BF \u03C6\u03AC\u03C1\u03BC\u03B1\u03BA\u03BF. \u03A4\u03BF 2019, \u03AE\u03C4\u03B1\u03BD \u03C4\u03BF 193\u03BF \u03C0\u03B9\u03BF \u03C3\u03C5\u03C7\u03BD\u03AC \u03C3\u03C5\u03BD\u03C4\u03B1\u03B3\u03BF\u03B3\u03C1\u03B1\u03C6\u03BF\u03CD\u03BC\u03B5\u03BD\u03BF \u03C6\u03AC\u03C1\u03BC\u03B1\u03BA\u03BF \u03C3\u03C4\u03B9\u03C2 \u0397\u03BD\u03C9\u03BC\u03AD\u03BD\u03B5\u03C2 \u03A0\u03BF\u03BB\u03B9\u03C4\u03B5\u03AF\u03B5\u03C2, \u03BC\u03B5 \u03C0\u03B5\u03C1\u03B9\u03C3\u03C3\u03CC\u03C4\u03B5\u03C1\u03B1 \u03B1\u03C0\u03CC 2 \u03B5\u03BA\u03B1\u03C4\u03BF\u03BC\u03BC\u03CD\u03C1\u03B9\u03B1 \u03C3\u03C5\u03BD\u03C4\u03B1\u03B3\u03AD\u03C2."@el . .